Norman, G.L.; Navaz, S.A.; Kanthi, Y.; Albesa, R.; Mahler, M.; Knight, J.S.; Zuo, Y.
Circulating Calprotectin as a Predictive and Severity Biomarker in Patients with COVID-19. Diagnostics 2022, 12, 1324.
https://doi.org/10.3390/diagnostics12061324
AMA Style
Norman GL, Navaz SA, Kanthi Y, Albesa R, Mahler M, Knight JS, Zuo Y.
Circulating Calprotectin as a Predictive and Severity Biomarker in Patients with COVID-19. Diagnostics. 2022; 12(6):1324.
https://doi.org/10.3390/diagnostics12061324
Chicago/Turabian Style
Norman, Gary L., Sherwin A. Navaz, Yogendra Kanthi, Roger Albesa, Michael Mahler, Jason S. Knight, and Yu Zuo.
2022. "Circulating Calprotectin as a Predictive and Severity Biomarker in Patients with COVID-19" Diagnostics 12, no. 6: 1324.
https://doi.org/10.3390/diagnostics12061324
APA Style
Norman, G. L., Navaz, S. A., Kanthi, Y., Albesa, R., Mahler, M., Knight, J. S., & Zuo, Y.
(2022). Circulating Calprotectin as a Predictive and Severity Biomarker in Patients with COVID-19. Diagnostics, 12(6), 1324.
https://doi.org/10.3390/diagnostics12061324